{"entity":{"id":"pharmacosmos","kind":"company","name":"Pharmacosmos","aka":["Pharmacosmos A/S"],"tldr":"Pharmacosmos is a Danish family-owned company specialising in intravenous iron; its iron isomaltoside (Monofer) treats the anaemia that chemotherapy and cancer itself cause, and it leads phase 3 trials in that setting.","summary":"Pharmacosmos A/S, founded in 1965 and based in Holbæk, Denmark, develops carbohydrate chemistry and intravenous iron products. Its iron isomaltoside 1000 (Monofer, ferric derisomaltose in the United States) is given as a single high-dose infusion for iron deficiency anaemia, including in patients with cancer, and the company has run phase 3 trials in cancer-related anaemia registered on ClinicalTrials.gov.","asOf":"2026-09-11","links":[{"label":"Official website","url":"http://www.pharmacosmos.com"},{"label":"ClinicalTrials.gov: trials led by Pharmacosmos A/S","url":"https://clinicaltrials.gov/search?lead=Pharmacosmos%20A%2FS"},{"label":"Wikidata","url":"https://www.wikidata.org/wiki/Q7180808"}],"tags":["ctgov-sponsor"],"related":[],"cancers":[],"sections":["supportive-care"],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["pivotal-trial","clinical-trial"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Holbæk","country":"DK","companyType":"pharma","website":"http://www.pharmacosmos.com","founded":1965,"stage":"private-large","investors":[],"funding":[]},"route":"/companies/pharmacosmos/","neighbours":{"section":[{"id":"supportive-care","kind":"section","name":"Supportive Care & Survivorship","route":"/fronts/supportive-care/"}],"term":[{"id":"clinical-trial","kind":"term","name":"Clinical trial","route":"/terms/clinical-trial/"},{"id":"pivotal-trial","kind":"term","name":"Pivotal (registrational) trial","route":"/terms/pivotal-trial/"}]}}